We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Morning Sickness Tied to Lower Pregnancy Loss

By HospiMedica International staff writers
Posted on 06 Oct 2016
A new study reveals that nausea and vomiting very early in pregnancy is associated with a reduced risk for miscarriage.

Researchers at the U.S. More...
National Institutes of Health (NIH, Bethesda, MD, USA), the University of Haifa (Israel), and other institutions conducted a randomized clinical trial to examine the association of nausea and vomiting during pregnancy with pregnancy loss. The study was a secondary analysis of data from a previous study that examined the effects of aspirin in gestation and reproduction that enrolled women with one or two prior pregnancy losses at four U.S. clinical centers from June 15, 2007, to July 15, 2011.

The secondary analysis was limited to 797 women with a pregnancy confirmed by positive results of a human chorionic gonadotropin (hCG) test. Nausea symptoms were drawn from daily preconception and pregnancy diaries for gestational weeks 2 to 8. From weeks 12 to 36, participants completed monthly questionnaires summarizing symptoms for the preceding four weeks. A week-level variable included nausea only, nausea with vomiting, or neither. The main outcomes were hCG-detected pregnancy without ultrasound evidence and clinically recognized pregnancy losses.

The results showed that 188 pregnancies (23.6%) ended in loss. At gestational week 2, 17.8% of the women reported nausea without vomiting, and 2.7% reported nausea with vomiting. By week 8, the proportions increased to 57.3% and 26.6%, respectively. The researchers found that nausea and nausea with vomiting were associated with a reduced risk for clinical pregnancy loss. The study was published on September 26, 2016, in JAMA Internal Medicine.

“Women who are concerned about their symptoms or their risk for a pregnancy loss should talk to their care provider who can counsel them about their risk for a loss, in the context of many other risk factors for pregnancy loss,” said lead author Stefanie Hinkle, PhD, of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development. “Our findings should be reassuring to women experiencing these symptoms; however, it is important for women who do not have these symptoms to understand that just because they do not have symptoms does not mean that they will go on to have a loss.”

Many theories have been proposed regarding the mechanism for an association between nausea and vomiting and pregnancy loss. First, symptoms may be part of an evolutionary advantage to change one’s dietary intake by increasing consumption of carbohydrate-rich foods, or by averting intake of potentially teratogenic substances. Second, the connection between nausea and pregnancy loss may be due to effects of hCG. A third possibility is that nausea and vomiting are markers for viable placental tissue; less nausea and vomiting may identify failing pregnancies.

Related Links:
U.S. National Institutes of Health
University of Haifa

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous kidney replacement therapy options for U.S. patients with acute kidney injury. (Photo courtesy of Fresenius Medical Care)

U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation

Critically ill patients with acute kidney injury often require continuous kidney replacement therapy in intensive care units. During these extracorporeal treatments, careful anticoagulation management... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.